Elinor C. Chumney

492 total citations
17 papers, 412 citations indexed

About

Elinor C. Chumney is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Family Practice. According to data from OpenAlex, Elinor C. Chumney has authored 17 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Geriatrics and Gerontology, 5 papers in Economics and Econometrics and 4 papers in Family Practice. Recurrent topics in Elinor C. Chumney's work include Pharmaceutical Practices and Patient Outcomes (7 papers), Medication Adherence and Compliance (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Elinor C. Chumney is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (7 papers), Medication Adherence and Compliance (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Elinor C. Chumney collaborates with scholars based in United States. Elinor C. Chumney's co-authors include Leslie Robinson, Kelly R. Ragucci, Joli D. Fermo, Kit N. Simpson, Andrea M. Wessell, Heather P. Whitley, Scott Brun, Michelle P. Luo, Talat Ashraf and Eugene Sun and has published in prestigious journals such as PharmacoEconomics, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and American Journal of Pharmaceutical Education.

In The Last Decade

Elinor C. Chumney

16 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elinor C. Chumney United States	12	165	80	77	69	67	17	412
Phantipa Sakthong Thailand	12	172 1.0×	60 0.8×	35 0.5×	54 0.8×	236 3.5×	35	546
Alemseged Beyene Berha Ethiopia	12	66 0.4×	28 0.3×	63 0.8×	66 1.0×	23 0.3×	30	304
Carla Torre Portugal	10	84 0.5×	70 0.9×	89 1.2×	31 0.4×	73 1.1×	43	524
Loice Achieng Kenya	8	31 0.2×	20 0.3×	67 0.9×	66 1.0×	60 0.9×	16	308
Nico Gabriel United States	9	142 0.9×	32 0.4×	59 0.8×	60 0.9×	129 1.9×	41	526
David J. Heller United States	12	31 0.2×	64 0.8×	50 0.6×	153 2.2×	153 2.3×	26	519
John Papastergiou Canada	12	95 0.6×	23 0.3×	57 0.7×	58 0.8×	45 0.7×	29	437
Qaiser Mukhtar United States	10	48 0.3×	92 1.1×	61 0.8×	131 1.9×	62 0.9×	22	463
Tamrat Befekadu Abebe Ethiopia	16	175 1.1×	29 0.4×	44 0.6×	268 3.9×	114 1.7×	34	670
Antonio Poncel-Falcó Spain	8	162 1.0×	43 0.5×	87 1.1×	37 0.5×	164 2.4×	9	642

Countries citing papers authored by Elinor C. Chumney

Since Specialization

Citations

This map shows the geographic impact of Elinor C. Chumney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elinor C. Chumney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elinor C. Chumney more than expected).

Fields of papers citing papers by Elinor C. Chumney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elinor C. Chumney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elinor C. Chumney. The network helps show where Elinor C. Chumney may publish in the future.

Co-authorship network of co-authors of Elinor C. Chumney

This figure shows the co-authorship network connecting the top 25 collaborators of Elinor C. Chumney. A scholar is included among the top collaborators of Elinor C. Chumney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elinor C. Chumney. Elinor C. Chumney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Garin, Margaret, Leslie L. Clark, Elinor C. Chumney, Kit N. Simpson, & Kristin B. Highland. (2009). Cost-Utility of Treatments for Pulmonary Arterial Hypertension. Clinical Drug Investigation. 29(10). 635–646. 34 indexed citations

Chumney, Elinor C., et al.. (2008). Impact of a Dual PharmD/MBA Degree on Graduates' Academic Performance, Career Opportunities, and Earning Potential. American Journal of Pharmaceutical Education. 72(2). 26–26. 17 indexed citations

Wiest, Donald B., Elinor C. Chumney, & Jean M. Nappi. (2008). Preadmission Predictors of Graduating Grade Point Average in a Professional Pharmacy Program. Journal of Pharmacy Technology. 24(1). 12–16. 5 indexed citations

Whitley, Heather P., Joli D. Fermo, Elinor C. Chumney, & Walter A. Brzezinski. (2007). Effect of patient-specific factors on weekly warfarin dose.. PubMed Central. 26 indexed citations

Jennings, Douglas L., Kelly R. Ragucci, Elinor C. Chumney, & Andrea M. Wessell. (2007). Impact of clinical pharmacist intervention on diabetes related quality-of-life in an ambulatory care clinic. Pharmacy Practice. 5(4). 169–73. 17 indexed citations

Simpson, Kit N., Michelle P. Luo, Elinor C. Chumney, Martin King, & Scott Brun. (2007). Cost Effectiveness of Lopinavir/Ritonavir Compared with Atazanavir in Antiretroviral-Naive Patients. Clinical Drug Investigation. 27(1). 67–74. 17 indexed citations

Chumney, Elinor C. & Kelly R. Ragucci. (2006). Student Satisfaction and Academic Performance in a Dual PharmD/MBA Degree Program. American Journal of Pharmaceutical Education. 70(2). 29–29.

Whitley, Heather P., Joli D. Fermo, & Elinor C. Chumney. (2006). 5‐Year Evaluation of Electronic Medical Record Flag Alerts for Patients Warranting Secondary Prevention of Coronary Heart Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(5). 682–688. 4 indexed citations

Chumney, Elinor C. & Kelly R. Ragucci. (2006). Student Satisfaction and Academic Performance in a Dual PharmD/MBA Degree Program. American Journal of Pharmaceutical Education. 70(2). 29–29. 17 indexed citations

10.

Chumney, Elinor C. & Leslie Robinson. (2006). Efectos de las intervenciones del farmacéutico en pacientes polimedicados. Pharmacy Practice. 4(3). 20 indexed citations

11.

Whitley, Heather P., Joli D. Fermo, Kelly R. Ragucci, & Elinor C. Chumney. (2006). Assessment of patient knowledge of diabetic goals, self-reported medication adherence, and goal attainment. Pharmacy Practice. 4(4). 183–183. 25 indexed citations

12.

Chumney, Elinor C. & Leslie Robinson. (2006). The effects of pharmacist interventions on patients with polypharmacy.. PubMed. 4(3). 103–9. 68 indexed citations

13.

Chumney, Elinor C., Patrick D. Mauldin, & Kit N. Simpson. (2006). Charges for hospital admissions attributable to health disparities for African-American patients, 1998-2002.. PubMed. 98(5). 690–4. 11 indexed citations

14.

Ragucci, Kelly R., Joli D. Fermo, Andrea M. Wessell, & Elinor C. Chumney. (2005). Effectiveness of Pharmacist‐Administered Diabetes Mellitus Education and Management Services. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(12). 1809–1816. 72 indexed citations

15.

Chumney, Elinor C., Andrea K. Biddle, Kit N. Simpson, et al.. (2004). The Effect of Cost Construction Based on Either DRG or ICD-9 Codes or Risk Group Stratification on the Resulting Cost-Effectiveness Ratios. PharmacoEconomics. 22(18). 1209–1216. 20 indexed citations

16.

Simpson, Kit N., Michelle P. Luo, Elinor C. Chumney, et al.. (2004). Cost-Effectiveness of Lopinavir/Ritonavir Versus Nelfinavir As the First-Line Highly Active Antiretroviral Therapy Regimen for HIV Infection. HIV Clinical Trials. 5(5). 294–304. 58 indexed citations

17.

Chumney, Elinor C. & Kit N. Simpson. (2002). The Emerging Role of the Consumer in Pharmaceutical Pricing Decisions. Disease Management & Health Outcomes. 10(4). 229–232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact